Long-term statin use associated with decreased risk of gallstones requiring surgery

November 10, 2009,

Use of the cholesterol-lowering drugs statins for more than a year is associated with a reduced risk of having gallstones requiring surgery, according to a study in the November 11 issue of JAMA.

In developed countries, approximately 10 percent to 20 percent of white adults have gallstones, which can cause pain and complications. is a leading cause of illness and inpatient admission in western countries and represents a serious burden for health care systems worldwide. More than 700,000 cholecystectomies (removal of the gallbladder) are performed annually in the United States, according to background information in the article.

Gallstones are classified as either cholesterol (80 percent-90 percent) or pigment stones (10 percent-20 percent), with cholesterol stones formed on the basis of cholesterol-supersaturated bile. "Statins decrease hepatic [liver] cholesterol biosynthesis and may therefore lower the risk of cholesterol gallstones by reducing the cholesterol concentration in the bile. Data on this association in humans are scarce," the authors write.

Michael Bodmer, M.D., M.Sc., of University Hospital, Basel, Switzerland, and colleagues conducted a large long-term observational study to examine the association between statin use and the risk of developing gallstone disease followed by cholecystectomy. The study included data from between 1994 and 2008 from the UK-based General Practice Research Database. A total of 27,035 patients with cholecystectomy and 106,531 matched controls were identified, including 2,396 patients and 8,868 controls who had statin use.

The researchers found that compared with nonuse, current statin use (last prescription recorded within 90 days before the first-time diagnosis of the disease) was 1.0 percent for patients and 0.8 percent for controls for 1 to 4 prescriptions; 2.6 percent vs. 2.4 percent for 5 to 19 prescriptions, and 3.2 percent vs. 3.7 percent for 20 or more prescriptions.

"This large observational study provides evidence that patients with long-term statin use have a reduced risk of gallstone disease followed by cholecystectomy compared with patients without statin use. However, the odds ratio was not decreased for patients with short-term statin use but started to decrease after 5 prescriptions, reflecting approximately 1 to 1.5 years of treatment. The risk estimate was consistent across age and sex groups. Adjustment for important risk factors for gallstone disease did not materially alter the results," the researchers write.

The authors add that the observed risk reduction suggests a class effect for all statins, and that there was a tendency toward a lower risk of gallstone disease for high-dose statin use compared with low-dose exposure. A substantially increased gallstone risk with cholecystectomy was found for patients with high body mass indexes and for patients with estrogen use.

"Our findings may be of clinical relevance given that gallstone disease represents a major burden for health care systems," the researchers conclude.

More information: JAMA. 2009;302[18]:2001-2007.

Source: JAMA and Archives Journals (news : web)

Related Stories

Recommended for you

Selection of a pyrethroid metabolic enzyme CYP9K1 by malaria control activities

April 20, 2018
Researchers from LSTM, with partners from a number of international institutions, have shown the rapid selection of a novel P450 enzyme leading to insecticide resistance in a major malaria vector.

Research finds new mechanism that can cause the spread of deadly infection

April 20, 2018
Scientists at the University of Birmingham have discovered a unique mechanism that drives the spread of a deadly infection.

Study predicts 2018 flu vaccine will have 20 percent efficacy

April 19, 2018
A Rice University study predicts that this fall's flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the ...

Zika presents hot spots in brains of chicken embryos

April 19, 2018
Zika prefers certain "hot spots" in the brains of chicken embryos, offering insight into how brain development is affected by the virus.

Low-cost anti-hookworm drug boosts female farmers' physical fitness

April 19, 2018
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in ...

Super-superbug clones invade Gulf States

April 18, 2018
A new wave of highly antibiotic resistant superbugs has been found in the Middle East Gulf States, discovered by University of Queensland researchers.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

jerryd
not rated yet Nov 11, 2009


Satin can hurt too. Lipitor gave me fibromialgia systems, bad muscle pain, severe weakness, enough to make me bed ridden in just 3 weeks and Zocor gave me depression after 6 months. Stopping them solved the problems. So be very careful of any medicine you take. Just because it help a lot doesn't mean they help all.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.